Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1992 2
1993 1
2001 1
2010 1
2013 1
2014 1
2015 1
2016 1
2017 1
2019 4
2020 4
2021 5
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.
Schepers M, Paes D, Tiane A, Rombaut B, Piccart E, van Veggel L, Gervois P, Wolfs E, Lambrichts I, Brullo C, Bruno O, Fedele E, Ricciarelli R, Ffrench-Constant C, Bechler ME, van Schaik P, Baron W, Lefevere E, Wasner K, Grünewald A, Verfaillie C, Baeten P, Broux B, Wieringa P, Hellings N, Prickaerts J, Vanmierlo T. Schepers M, et al. Among authors: paes d. Brain Behav Immun. 2023 Mar;109:1-22. doi: 10.1016/j.bbi.2022.12.020. Epub 2022 Dec 28. Brain Behav Immun. 2023. PMID: 36584795 Free article.
Improving the vaccination experience for our patients.
Paes D, Tsuyuki RT. Paes D, et al. Can Pharm J (Ott). 2022 Dec 15;156(1 Suppl):6S. doi: 10.1177/17151635221142561. eCollection 2023 Jan-Feb. Can Pharm J (Ott). 2022. PMID: 36756626 Free PMC article. No abstract available.
Phosphodiesterase Type 4 Inhibition in CNS Diseases.
Blokland A, Heckman P, Vanmierlo T, Schreiber R, Paes D, Prickaerts J. Blokland A, et al. Among authors: paes d. Trends Pharmacol Sci. 2019 Dec;40(12):971-985. doi: 10.1016/j.tips.2019.10.006. Epub 2019 Nov 5. Trends Pharmacol Sci. 2019. PMID: 31704172 Review.
Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology.
Paes D, Schepers M, Willems E, Rombaut B, Tiane A, Solomina Y, Tibbo A, Blair C, Kyurkchieva E, Baillie GS, Ricciarelli R, Brullo C, Fedele E, Bruno O, van den Hove D, Vanmierlo T, Prickaerts J. Paes D, et al. Cell Mol Life Sci. 2023 Jun 12;80(7):178. doi: 10.1007/s00018-023-04804-w. Cell Mol Life Sci. 2023. PMID: 37306762 Free PMC article.
CPO Update: Diversity, Equity and Inclusion.
Paes D. Paes D. Can Pharm J (Ott). 2022 Apr 15;155(3):150. doi: 10.1177/17151635221094196. eCollection 2022 May-Jun. Can Pharm J (Ott). 2022. PMID: 35519082 Free PMC article. No abstract available.
CPhA launches Pharmacy Workforce Wellness initiative.
Paes D. Paes D. Can Pharm J (Ott). 2022 Feb 14;155(2):85. doi: 10.1177/17151635221080498. eCollection 2022 Mar-Apr. Can Pharm J (Ott). 2022. PMID: 35300020 Free PMC article. No abstract available.
PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity.
Rombaut B, Kessels S, Schepers M, Tiane A, Paes D, Solomina Y, Piccart E, van den Hove D, Brône B, Prickaerts J, Vanmierlo T. Rombaut B, et al. Among authors: paes d. Theranostics. 2021 Jan 1;11(5):2080-2097. doi: 10.7150/thno.50701. eCollection 2021. Theranostics. 2021. PMID: 33500712 Free PMC article. Review.
31 results